Shorts

0:46
How AI is Revolutionizing Clinical Trials
5 months ago
by
Danny Nguyen, MD

0:57
Why Clinical Trials Aren't Just a Last Resort for Cancer
5 months ago
by
Danny Nguyen, MD

0:55
Big Shifts Ahead in Lung Cancer: New KRAS Data and Paradigm Changes
5 months ago
by
Christine Bestvina, MD

0:28
Decentralized Clinical Trials: Reducing the Logistical Burden of Participation
5 months ago
by
Inna Gong, MD, PhD

1:18
Why Women Face Longer Delays in Lung Cancer Diagnosis
5 months ago
by
Narjust Florez, MD

0:57
A “Cancer Genome Atlas” for Immune Profiles?
5 months ago
by
Won Jin Ho, MD

0:32
Confronting Feelings of Guilt in Younger Patients
5 months ago
by
Narjust Florez, MD

0:51
Why Young Women's Lung Cancer Symptoms Are Often Ignored
5 months ago
by
Narjust Florez, MD

1:07
Why ZIP Code Shouldn't Determine Cancer Outcomes
5 months ago
by
Pallav K. Mehta, MD(+1 more)

0:52
Guideline Updates in Lymphoma Treatment
5 months ago
by
Hua-Jay "Jeff" Cherng, MD

0:31
Why You Shouldn't Wait to Treat MDS
5 months ago
by
David Sallman, MD

0:32
My Strategy for MDS Patients Waiting Transplant
5 months ago
by
David Sallman, MD

0:50
Why Haven't Trial Participation Rates Improved?
5 months ago
by
Inna Gong, MD, PhD

0:55
Combating Misinformation: The Truth About the HPV Vaccine
5 months ago
by
Natalie Berger, MD

0:30
Are We Being Too Strict With Clinical Trial Eligibility?
5 months ago
by
Christine Bestvina, MD

0:33
Why Lung Cancer is Now "12 Different Diseases"
5 months ago
by
Christine Bestvina, MD

1:04
MajesTEC-3 Outcomes Lead to Rapid Myeloma Combo Approval
5 months ago
by
Luciano Costa, MD, PhD

0:47
The Problem With MRD Testing in Breast Cancer
5 months ago
by
Paolo Tarantino, MD

1:30
How Mezigdomide Reinvigorates the Immune System
5 months ago
by
Paul G. Richardson, MD

0:31
Mapping Therapy-Driven Immune Changes in Metastatic PDAC
5 months ago
by
Won Jin Ho, MD

1:08
Is 2026 the Pivotal Year for Liquid Biopsies in Breast Cancer?
5 months ago
by
Paolo Tarantino, MD

0:39
Overlaps in Breast and Gynecologic Cancer Treatments
5 months ago
by
Natalie Berger, MD

0:34
The Future of Personalized Kidney Cancer Treatment
5 months ago
by
Karie Runcie, MD

1:30
Predicting Melanoma Treatment Success After 3-4 Weeks
5 months ago
by
Vincent Ma, MD

0:55
Intravesical Erdafitinib Evaluated in Phase 1 NMIBC Trial
5 months ago
by
Antoni Vilaseca Cabo, MD

0:42
Exploring Immune Data to Guide Pancreatic Cancer Immunotherapy
5 months ago
by
Won Jin Ho, MD

0:41
How MRD Could Fast-Track Cancer Breakthroughs
5 months ago
by
Sagar Lonial, MD, FACP

1:03
Why Bone Health Is Crucial in Prostate Cancer Treatment
5 months ago
by
Daniel P. Petrylak, MD

0:38
Why PSMA PET Is the New Gold Standard for Prostate Cancer
5 months ago
by
Scott Tagawa, MD, MS, FACP, FASCO

0:35
Impressive Durability in New Cancer Combo Therapy
5 months ago
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
mRNA Vaccine Plus Pembrolizumab Yields RFS, DMFS Benefit in Resectable Melanoma
2
FDA Grants ETX-19477 Fast Track Designation in BRCA-Mutated Breast Cancer
3
FDA Grants Fast Track Designation to Piktor in Endometrial Cancer
4
FDA Grants Fast Track Designation to BH-30643 in EGFR C797S+ NSCLC
5
